Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-CD48 Antibody

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T9901A-1257 Copy Product Info
🥰Excellent
Anti-CD48 Antibody is a humanized monoclonal antibody targeting CD48 (SLAMF2/BLAST-1). CD48 is a GPI-anchored cell surface glycoprotein belonging to the Signaling Lymphocyte Activation Molecule (SLAM) family, widely expressed on lymphocytes, monocytes, and endothelial cells. It serves as a high-affinity ligand for the NK cell receptor 2B4 (CD244) and the T cell receptor CD2, playing a role in mediating immune cell adhesion, activation, and co-stimulatory signaling. Research indicates that CD48 is highly expressed on the surface of hematologic malignancies such as multiple myeloma (MM). By specifically binding to CD48, Anti-CD48 Antibody not only blocks its interaction with ligands but also induces potent Antibody-Dependent Cellular Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC), leading to direct tumor cell killing. It is a significant candidate tool for researching immunotherapy in hematological cancers.

Anti-CD48 Antibody

Pack SizePriceUSA StockGlobal StockQuantity
1 mg$238InquiryInquiry
5 mg$718InquiryInquiry
10 mg$1,150InquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-CD48 Antibody is a humanized monoclonal antibody targeting CD48 (SLAMF2/BLAST-1). CD48 is a GPI-anchored cell surface glycoprotein belonging to the Signaling Lymphocyte Activation Molecule (SLAM) family, widely expressed on lymphocytes, monocytes, and endothelial cells. It serves as a high-affinity ligand for the NK cell receptor 2B4 (CD244) and the T cell receptor CD2, playing a role in mediating immune cell adhesion, activation, and co-stimulatory signaling. Research indicates that CD48 is highly expressed on the surface of hematologic malignancies such as multiple myeloma (MM). By specifically binding to CD48, Anti-CD48 Antibody not only blocks its interaction with ligands but also induces potent Antibody-Dependent Cellular Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC), leading to direct tumor cell killing. It is a significant candidate tool for researching immunotherapy in hematological cancers.
In vitro
Anti-CD48 Antibody binds CD48 with high specificity and induces significant ADCC and CDC against CD48-positive multiple myeloma cells. It also disrupts the CD48-2B4 interaction, modulating NK cell activation [1][2].
In vivo
In multiple myeloma xenograft models, systemic administration of Anti-CD48 Antibody significantly inhibits tumor growth and prolongs survival without significant toxicity [1].
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetCD48
Antibody Information
IsotypeIgG4 (S228P)
Recommended Isotype Control
Storage & Solubility Information
StorageStore at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: Anti-CD48 Antibody in vivo | Anti-CD48 Antibody in vitro